The spine field has seen important advances in treatments but there are some areas that have yet to be solved, Roger Härtl, MD, said. Dr. Härtl, of Och Spine at NewYork-Presbyterian/Weill Cornell ...
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback